Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323.

Article  PubMed  Google Scholar 

Adal E, Koyuncu G, Aydın A, Celebi A, Kavunoğlu G, Cam H. Asymptomatic cardiomyopathy in children and adolescents with type 1 diabetes mellitus: association of echocardiographic indicators with duration of diabetes mellitus and metabolic parameters. J Pediatr Endocrinol Metab. 2006;19:713–26.

Article  PubMed  Google Scholar 

El Razaky O, El Amrousy D, Elrifaey S, Elgendy M, Ibrahim W. Three-dimensional speckle tracking echocardiography: is it the magic wand in the diagnosis of subclinical myocardial dysfunction in children with type 1 diabetes mellitus? Echocardiography. 2018;35(10):1657–63.

Article  PubMed  Google Scholar 

Vazeou A, Papadopoulou A, Miha M, Drakatos A, Georgacopoulos D. Cardiovascular impairment in children, adolescents, and young adults with type 1 diabetes mellitus (T1DM). Eur J Pediatr. 2008;167:877–84.

Article  CAS  PubMed  Google Scholar 

Khattab AA, Soliman MA. Biventricular function and glycemic load in type 1 diabetic children: Doppler tissue-imaging study. Pediatr Cardiol. 2015;36:423–31.

Article  PubMed  Google Scholar 

Ward ML, Crossman DJ. Mechanisms underlying the impaired contractility of diabetic cardiomyopathy. World J Cardiol. 2014;6(7):577–84.

Article  PubMed  PubMed Central  Google Scholar 

Hensel KO, Grimmer F, Roskopf M, Jenke AC, Wirth S, Heusch A. Subclinical alterations of cardiac mechanics present early in the course of pediatric type 1 diabetes mellitus: a prospective blinded speckle tracking stress echocardiography study. J Diabetes Res. 2016;2016:12.

Article  Google Scholar 

Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):1501–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drimal J, Knezl V, Navarova J, Nedelcevova J, Paulovicova E, Sotnikova R, et al. Role of inflammatory cytokines and chemoattractants in the rat model of streptozotocin induced diabetic heart failure. Endocr Regul. 2008;42:129–35.

CAS  PubMed  Google Scholar 

Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuleta I, Frangogiannis NG. Diabetic fibrosis. Biochim Biophys Acta Mol Basis Dis. 2021;1867: 166044.

Article  CAS  PubMed  Google Scholar 

Adam SH, Mohd Nasri N, Kashim MIAM, Abd Latib EH, Ahmad Juhari MAA, Mokhtar MH. Potential health benefits of Nigella sativa on diabetes mellitus and its complications: a review from laboratory studies to clinical trials. Front Nutr. 2022;9:1057825.

Article  PubMed  PubMed Central  Google Scholar 

Maideen NMP, Balasubramanian R, Ramanathan S. Nigella sativa (black seeds), a potential herb for the pharmacotherapeutic management of hypertension. Curr Cardiol Rev. 2021;17(4): e230421187786.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pop RM, Trifa AP, Popolo A, Chedea VS, Militaru C, Bocsan IC, et al. Nigella sativa: valuable perspective in the management of chronic diseases. Iran J Basic Med Sci. 2020;23(6):699–713.

PubMed  PubMed Central  Google Scholar 

Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, McVicar J, Hadi V, Soleimani D, et al. Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2021;35(7):3747–55.

Article  CAS  PubMed  Google Scholar 

Bamosa A, Kaatabi H, Badar A, Al-Khadra A, Al Elq A, Abou-Hozaifa B, et al. Nigella sativa: a potential natural protective agent against cardiac dysfunction in patients with type 2 diabetes mellitus. Fam Commun Med. 2015;22(2):88–95.

Article  Google Scholar 

Badar A, Kaatabi H, Bamosa A, Al-Elq A, Abou-Hozaifa B, Lebda F, et al. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. Ann Saudi Med. 2017;37(1):56–63.

Article  PubMed  PubMed Central  Google Scholar 

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.

Article  CAS  PubMed  Google Scholar 

Draper H, Hadly M. Malonaldehyde determination as an index of lipid peroxidation. Methods Enzymol. 1990;186:421–31.

Article  CAS  PubMed  Google Scholar 

Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5:62–71.

Article  CAS  PubMed  Google Scholar 

Hegazy SK, Tolba OA, Mostafa TM, Eid MA, El-Afify DR. Alpha lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes. Rev Diabet Stud. 2013;10(1):58–67.

Article  PubMed  PubMed Central  Google Scholar 

Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson A, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet. 2011;378:140–6.

Article  PubMed  Google Scholar 

Julián MT, Pérez-Montes de Oca A, Julve J, Alonoso N. The double burden: type 1 diabetes and heart failure—a comprehensive review. Cardiovasc Diabetol. 2024;23(1):65.

Article  PubMed  PubMed Central  Google Scholar 

Segre CA, Hueb W, Garcia RM, Rezende PC, Favarato D, Strunz CM, et al. Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovasc Disord. 2015;15:72.

Article  PubMed  PubMed Central  Google Scholar 

Rubin J, Matsushita K, Ballantyne CM, Hoogeveen R, Coresh J, Selvin E. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol. 2012;59:484–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casey TM, Arthur PG, Bogoyevitch MA. Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stress. Biochim Biophys Acta. 2007;1773:342–51.

Article  CAS  PubMed  Google Scholar 

Homma TK, Endo CM, Saruhashi T, Mori AP, de Noronha RM, Monte O, et al. Dyslipidemia in young patients with type 1 diabetes mellitus. Arch Endocrinol Metab. 2015;59:215–9.

Article  PubMed  Google Scholar 

Kim SH, Jung IA, Jeon YJ, Cho WK, Cho KS, Park SH, et al. Serum lipid profiles and glycemic control in adolescents and young adults with type 1 diabetes mellitus. Ann Pediatr Endocrinol Metab. 2014;19:191–6.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Xiao Y, Hu J, Liu S, Zhou Z, Xie L. Lipid metabolism in type 1 diabetes mellitus: pathogenetic and therapeutic implications. Front Immunol. 2022;13: 999108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ke J, Pan J, Lin H, Gu J. Diabetic cardiomyopathy: a brief summary on lipid toxicity. ESC Heart Fail. 2023;10(2):776–90.

Article  PubMed  Google Scholar 

Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother Res. 2020;34(10):2706–11.

Article  CAS  PubMed  Google Scholar 

Pelegrin S, Galtier F, Chalançon A, Gagnol JP, Barbanel AM, Pélissier Y, et al. Effects of Nigella sativa seeds (black cumin) on insulin secretion and lipid profile: a pilot study in healthy volunteers. Br J Clin Pharmacol. 2019;85(7):1607–11.